Evan Feinberg

CEO & Co-Founder at Genesis Therapeutics

Evan received a degree in physics from Yale and a biophysics Ph.D. from Stanford working in Vijay Pande's lab. During his time at Stanford, he invented PotentialNet and consulted on deep learning for big pharma. Evan was also an early software engineer on the MoleculeNet and DeepChem open source projects.

Links

Previous companies

Yale University logo
Merck logo
Memorial Sloan - Kettering Cancer Center logo

Timeline

  • CEO & Co-Founder

    March, 2019 - present